Riskpilot← Back to searchSign inGet full accessJE Optik & Synvård AB
ABActiveOrg 5591102420Vendevägen 12Retail sale of medical and orthopaedic goods · NACE 4774Est. 20175 employees
Revenue 2025
SEK 8,6M
+7% vs 2024
EBITDA margin
18.6%
+1% vs 2024
Equity ratio
26.0%
Financial strength
Net profit 2025
SEK 1,1M
-10% vs 2024
| Revenue | SEK 8,6M | +7% |
| EBITDA | SEK 1,6M | +1% |
| Net profit | SEK 1,1M | -10% |
| Total assets | SEK 4,4M | +8% |
| Equity | SEK 1,1M | -9% |
| Employees | 5 | — |
Legal name
JE Optik & Synvård AB
Org number
5591102420
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
27 april 2017
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Renge, Karin Johanna
Company purpose
Konsulttjänster inom optik och synvård. Samt detaljhandel inom otptik och synvård.
Address
Vendevägen 12
Email
johanna@djursholmsoptik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 865 | 6 416 | 7 960 | 8 112 | 8 643 |
| Staff expenses | — | — | — | −2 932 | −3 209 |
| EBITDA | 1 257 | 1 529 | 1 628 | 1 588 | 1 606 |
| Depreciation & amort. | −109 | −152 | −170 | −205 | −253 |
| EBIT | 1 148 | 1 377 | 1 458 | 1 383 | 1 352 |
| Net financials | −1 | 10 | 40 | 143 | 26 |
| Profit before tax | 856 | 1 028 | 1 498 | 1 525 | 1 378 |
| Tax | −186 | −221 | −314 | −332 | −302 |
| Net profit | 670 | 807 | 1 184 | 1 193 | 1 076 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 897 | 4 190 | 5 387 | 4 017 | 4 353 |
| Equity | 1 579 | 2 086 | 3 269 | 1 244 | 1 130 |
| Long-term debt | 140 | 140 | 0 | — | — |
| Short-term debt | 691 | 1 118 | 1 271 | 1 927 | 2 377 |
| Total debt | 831 | 1 258 | 1 271 | 1 927 | 2 377 |
EBITDA margin
18.6%
This company
15.8%
Market median
+18% vs market
20212025
Equity ratio
26.0%
This company
38.2%
Market median
-32% vs market
20212025
Return on equity
95.3%
This company
18.4%
Market median
+418% vs market
20212025
Net profit margin
12.5%
This company
8.1%
Market median
+54% vs market
20212025
Asset turnover
1.99×
This company
1.12×
Market median
+78% vs market
20212025
Debt / equity
2.85×
This company
0.62×
Market median
-360% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JH | Audit | 2022 |
KJ Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Renge Holding AB
JE Optik & Synvård AB Board members of JE Optik & Synvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Hans Fredrik Eriksson | Audit | 0 companies |
| Karin Johanna Renge | Chief Executive Officer | 0 companies |
| Julia Elsa Edholm | Board of Directors | 0 companies |
| Sven Johan Kristofer Renge | Chairman | 0 companies |
| Maja Blenda Edholm | Board of Directors | 0 companies |